Clinical information

Diagnostic Utility:

This test quantifies cellular viability in thawed clinical samples of umbilical cord blood and thawed or post-thaw hematopoietic progenitor samples for clinical use. It is also used to evaluate cellular viability in cell culture samples for research projects.

Method

Manual count in a Neubauer chamber.

Reference Values

The results are quantitative. The expected values are as follows:

Sample Trypan Blue Viability (%)
UCB (thawed) ≥40
Hematopoietic progenitors ≥70
Cell cultures (fresh) ≥70

Diagnostic Algorithm:

Not applicable.

Turnaround Time:

1 day.

Specimen information

Sample: Thawed umbilical cord blood; thawed bone marrow/apheresis or post-night and cell cultures.
Tube: Additive-free tube
Minimum volume: 100 µL

Stability:

  • Cell culture sample: 1 day
  • Thawed/post-night samples: 1 hour

Transport instructions: Culture and post-night samples at room temperature; thawed samples with refrigerated transport.

Reason for rejection: Sample with clots.

Administrative information

BST Code: CEL013
Test Description: Determination of cell viability with Trypan blue.
Synonyms: BT
Section: Cellular Laboratory
BST Rate: Check the updated rates here.

Profiles:

The CEL013 test Trypan Blue Viability can be requested alone. It is also performed within the following profiles:

Profile Name Profile Code
SCU POST-WASH CEL5
SCU SE CEL1
AFE AUTO POSTNIGHT CEL15
TUB A AUTO CEL7
TUB A ALLO CEL8
TUB B/C AUTO CEL9
TUB B/C ALLO CEL10
TUB A/B/C ALLOQUOT/ CART CEL11

References

Strober W; Curr Protoc Immunol. 2015 Nov 2;111:A3.B.1-A3.B.3.

Quality

BST holds ISO 9001, ISO 14001, and OSHAS 18001 quality certifications, as well as the European Excellence 500+ seal. BST is accredited by CAT, JACIE-FACT, FACT-NETCORD, and EFI, and complies with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines.